These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10069947)

  • 1. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
    Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
    Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mouse lines transgenic with the human poliovirus receptor gene.
    Deatly AM; Taffs RE; McAuliffe JM; Nawoschik SP; Coleman JW; McMullen G; Weeks-Levy C; Johnson AJ; Racaniello VR
    Microb Pathog; 1998 Jul; 25(1):43-54. PubMed ID: 9705248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
    Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
    Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
    Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I; Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The observation on infection of trasgenic mice (PVR Tg21) with polioviruses type 3].
    Guo R; Chen S; Luo Q; Wang Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):70-5. PubMed ID: 11367738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
    J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde transport of intact poliovirus through the axon via the fast transport system.
    Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
    Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
    Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
    Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
    Dai C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of poliovirus neurovirulence.
    Ohka S; Nomoto A
    Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus neurovirulence and attenuation, a conceptual framework.
    John TJ
    Dev Biol Stand; 1993; 78():117-9. PubMed ID: 8388822
    [No Abstract]   [Full Text] [Related]  

  • 19. Random selection: a model for poliovirus infection of the central nervous system.
    Georgescu MM; Balanant J; Ozden S; Crainic R
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1819-28. PubMed ID: 9266975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
    Dragunsky E; Taffs R; Chernokhvostova Y; Nomura T; Hioki K; Gardner D; Norwood L; Levenbook I
    Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.